McKinsey agrees $600m settlement over role in opioids crisis

Company expresses deep regret' for consulting businesses on how to sell more prescription painkillers amid a nationwide crisis

The McKinsey business consultancy has agreed to pay nearly $600m for its role in consulting businesses on how to sell more prescription opioid painkillers amid a nationwide overdose crisis.

We deeply regret that we did not adequately acknowledge the tragic consequences of the epidemic unfolding in our communities," McKinsey global managing partner Kevin Sneader said in a statement on Thursday, adding with this agreement, we hope to be part of the solution to the opioid crisis in the US."